MedTrace Logo

VR Mindfulness for People With HIV and Substance Use

NCT07088289 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-28

No results posted yet for this study

Summary

The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems.

Participants will:

* Use a VR headset with a mindfulness app at home;
* Complete three online surveys over three months;
* Take part in an individual interview or focus group to share their experiences.

Conditions

  • HIV
  • Substance Use (Drugs, Alcohol)

Interventions

BEHAVIORAL

TRIPP

In this study, participants will use TRIPP with a VR headset at home, engaging in short mindfulness sessions 3+ times per week for 4-12 weeks.

Sponsors & Collaborators

  • Tulane University

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-05-31
Completion
2027-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088289 on ClinicalTrials.gov